Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07801859 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 3, 2026 (before its estimated October 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level and re-ascent from sea level to 2850m on heart rate variability and other hemodynamic parameters in patients with pulmonary arterial hypertension PAH, who live permanently \>2600m.
Trial Details
NCT Number NCT07801859
Lead Sponsor Silvia Ulrich Somaini
Conditions
(from sponsor)		 High Altitude Effects, High Altitude, Pulmonary Vascular Disease, Pulmonary Arterial Hypertension (PAH), Heart Rate Variability (HRV), ECG Abnormalities
Related terms Altitude Sickness, Hypertension, Pulmonary, Pulmonary Arterial Hypertension
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov